1. Home
  2. DSX vs OBIO Comparison

DSX vs OBIO Comparison

Compare DSX & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Diana Shipping inc. common stock

DSX

Diana Shipping inc. common stock

HOLD

Current Price

$2.73

Market Cap

273.7M

ML Signal

HOLD

Logo Orchestra BioMed Holdings Inc.

OBIO

Orchestra BioMed Holdings Inc.

HOLD

Current Price

$5.07

Market Cap

253.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSX
OBIO
Founded
1999
2017
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
273.7M
253.9M
IPO Year
2005
2020

Fundamental Metrics

Financial Performance
Metric
DSX
OBIO
Price
$2.73
$5.07
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$14.25
AVG Volume (30 Days)
911.8K
299.8K
Earning Date
05-28-2026
05-11-2026
Dividend Yield
1.62%
N/A
EPS Growth
N/A
33.13
EPS
N/A
N/A
Revenue
N/A
$33,482,000.00
Revenue This Year
$14.28
N/A
Revenue Next Year
$4.87
$12.43
P/E Ratio
$16.02
N/A
Revenue Growth
N/A
1169.22
52 Week Low
$1.57
$2.20
52 Week High
$2.92
$5.78

Technical Indicators

Market Signals
Indicator
DSX
OBIO
Relative Strength Index (RSI) 64.34 58.82
Support Level $2.27 $3.72
Resistance Level $2.90 $5.42
Average True Range (ATR) 0.09 0.31
MACD 0.01 -0.01
Stochastic Oscillator 86.73 54.43

Price Performance

Historical Comparison
DSX
OBIO

About DSX Diana Shipping inc. common stock

Diana Shipping Inc provides shipping transportation services. The company, through its subsidiaries, operates a fleet of vessels consisting of dry bulk carriers such as Panamax, Kamsarmax, Post-Panamax, Capesize, and Newcastlemax vessels. Using this fleet, the firm provides transportation services for various goods, including coal, iron ore, and grains. It also transports minor bulks, including steel products, cement, and fertilizers, through its dry bulk carrier vessels. The operation of the vessels is the main source of revenue generation; the services provided by the vessels are similar, and all operate under the same economic environment.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.

Share on Social Networks: